KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Inventory Average (2016 - 2022)

TherapeuticsMD (TXMD) has disclosed Inventory Average for 10 consecutive years, with $6.4 million as the latest value for Q3 2022.

  • For the quarter ending Q3 2022, Inventory Average fell 13.96% year-over-year to $6.4 million, compared with a TTM value of $6.4 million through Sep 2022, down 13.96%, and an annual FY2021 reading of $7.8 million, down 21.35% over the prior year.
  • Inventory Average was $6.4 million for Q3 2022 at TherapeuticsMD, down from $7.6 million in the prior quarter.
  • Across five years, Inventory Average topped out at $13.2 million in Q1 2020 and bottomed at $1.6 million in Q1 2018.
  • Average Inventory Average over 5 years is $7.1 million, with a median of $7.5 million recorded in 2021.
  • The sharpest move saw Inventory Average surged 323.3% in 2019, then plummeted 42.05% in 2021.
  • Year by year, Inventory Average stood at $2.8 million in 2018, then surged by 296.63% to $11.2 million in 2019, then decreased by 19.95% to $9.0 million in 2020, then dropped by 16.41% to $7.5 million in 2021, then dropped by 14.24% to $6.4 million in 2022.
  • Business Quant data shows Inventory Average for TXMD at $6.4 million in Q3 2022, $7.6 million in Q2 2022, and $8.3 million in Q1 2022.